affiliation not provided to SSRN
international consortia, knowledge-based plan prediction, models' transferability, whole-breast radiotherapy
EPID, QA, In-vivo dosimetry, commissioning
EPID in vivo dose (EIVD), IGRT protocol, breast cancer radiotherapy, Tumor Control Probability (TCP), Lifetime attributable risk (LAR)